Thriving Together: 2021 Virtual Conference on Metastatic Breast Cancer

Inavolisib (Itovebi) is a new targeted therapy shown to reduce progression of certain hormone receptor-positive, HER2-negative, PIK3CA-positive metastatic breast cancers.

Next-generation sequencing (NGS) is a testing technology that uses computers to look at hundreds of genes in cancer cells. The results can help guide treatment decisions.

A FISH test is a lab test performed on tissue taken from a biopsy or breast cancer surgery, that can confirm breast cancer’s HER2 status if other test results are inconclusive.

Some of the most important breast cancer treatment decisions are based on immunohistochemistry (IHC) tests; hormone receptor status, HER2 status, and in some cases, PD-L1 status.

Circulating tumor cell (CTC) tests can help monitor whether treatment is working or if breast cancer has metastasized.

A metastatic breast cancer diagnosis can bring concerns about extra costs, your financial well-being, and your job. On these pages you can learn how to get ahead of unexpected medical and living expenses.

Read More

 | 2 Min. Read |  5

Your job and your career path may be very important to you for financial and personal reasons. It’s normal to worry that a metastatic breast cancer diagnosis could affect your ability to work and earn a living. 

Understanding your health insurance options and what they cover is an important part of managing the costs of any long-term illness.

Read More

 | 12 Min. Read |  2

With a diagnosis of metastatic breast cancer, there are enough changes to navigate without the stress of financial uncertainty.

The goal of metastatic breast cancer treatment is to manage the disease while limiting side effects. Learn about available treatments and when they are used.

Read More

 | 22 Min. Read |  4